CHRDL1 Antikörper (N-Term)
Kurzübersicht für CHRDL1 Antikörper (N-Term) (ABIN951513)
Target
Alle CHRDL1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 5-35, N-Term
-
Spezifität
- This antibody recognizes CHRDL1 / NRLN1.
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human
-
Aufreinigung
- Purified through a Protein A column followed by peptide affinity purification
-
Immunogen
- Synthetic peptide - KLH conjugated - corresponding to the N-terminal region (between 5-35aa) of human CHRDL1 / NRLN1
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) Sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- CHRDL1 (Chordin-Like 1 (CHRDL1))
-
Andere Bezeichnung
- CHRDL1 / NRLN1
-
Hintergrund
- CHRDL1 is an antagonist of bone morphogenetic protein 4. The encoded protein may play a role in topographic retinotectal projection and in the regulation of retinal angiogenesis in response to hypoxia. Alternatively spliced transcript variants encoding different isoforms have been described.Synonyms: Chordin-like protein 1, Neuralin-1, Neurogenesin-1, Ventroptin
-
Gen-ID
- 91851
-
NCBI Accession
- NP_001137453
Target
-